Simplex Trading, LLC Esperion Therapeutics, Inc. Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

A detailed history of Simplex Trading, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 104,359 shares of ESPR stock, worth $230,633. This represents 0.01% of its overall portfolio holdings.

Number of Shares
104,359
Previous 91,844 13.63%
Holding current value
$230,633
Previous $203,000 15.27%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$1.61 - $2.73 $20,149 - $34,165
12,515 Added 13.63%
104,359 $172,000
Q2 2024

Jul 25, 2024
BUY
$1.84 - $3.24 $168,992 - $297,574
91,844 New
91,844 $203,000
Q3 2023

Nov 01, 2023
SELL
$0.96 - $1.79 $41,018 - $76,483
-42,728 Reduced 80.1%
10,618 $10,000
Q2 2023

Aug 04, 2023
SELL
$1.2 - $1.76 $50,697 - $74,356
-42,248 Reduced 44.2%
53,346 $74,000
Q1 2023

Apr 27, 2023
SELL
$1.46 - $7.3 $63,996 - $319,980
-43,833 Reduced 31.44%
95,594 $151,000
Q4 2022

Feb 02, 2023
BUY
$5.09 - $8.5 $709,683 - $1.19 Million
139,427 New
139,427 $868,000
Q3 2021

Oct 28, 2021
SELL
$11.34 - $21.37 $1,134 - $2,137
-100 Reduced 0.67%
14,802 $316,000
Q2 2021

Aug 12, 2021
BUY
$19.4 - $28.71 $173,552 - $256,839
8,946 Added 150.2%
14,902 $315,000
Q1 2021

Apr 26, 2021
SELL
$25.12 - $36.89 $108,116 - $158,774
-4,304 Reduced 41.95%
5,956 $167,000
Q4 2020

Feb 02, 2021
SELL
$24.2 - $35.76 $196,600 - $290,514
-8,124 Reduced 44.19%
10,260 $266,000
Q3 2020

Oct 14, 2020
SELL
$31.18 - $52.71 $32,021 - $54,133
-1,027 Reduced 5.29%
18,384 $683,000
Q2 2020

Jul 13, 2020
SELL
$30.04 - $51.31 $680,135 - $1.16 Million
-22,641 Reduced 53.84%
19,411 $995,000
Q1 2020

Apr 29, 2020
BUY
$27.44 - $73.84 $896,711 - $2.41 Million
32,679 Added 348.65%
42,052 $1.33 Million
Q4 2019

Feb 05, 2020
BUY
$35.4 - $59.82 $122,908 - $207,695
3,472 Added 58.84%
9,373 $558,000
Q3 2019

Oct 15, 2019
SELL
$34.47 - $47.53 $352,972 - $486,707
-10,240 Reduced 63.44%
5,901 $216,000
Q2 2019

Jul 26, 2019
BUY
$40.1 - $52.33 $137,663 - $179,648
3,433 Added 27.01%
16,141 $750,000
Q1 2019

Apr 18, 2019
SELL
$40.11 - $53.57 $43,198 - $57,694
-1,077 Reduced 7.81%
12,708 $0
Q4 2018

Jan 16, 2019
BUY
$36.99 - $59.11 $374,634 - $598,666
10,128 Added 276.95%
13,785 $634,000
Q3 2018

Oct 23, 2018
BUY
$40.74 - $51.41 $47,217 - $59,584
1,159 Added 46.4%
3,657 $162,000
Q2 2018

Jul 30, 2018
BUY
$36.2 - $76.4 $48,363 - $102,070
1,336 Added 114.97%
2,498 $97,000
Q1 2018

Apr 26, 2018
BUY
$65.94 - $80.76 $76,622 - $93,843
1,162 New
1,162 $84,000
Q4 2017

Jan 10, 2018
SELL
$43.47 - $67.43 $171,402 - $265,876
-3,943 Closed
0 $0
Q3 2017

Oct 25, 2017
BUY
$43.8 - $52.77 $172,703 - $208,072
3,943
3,943 $197,000

Others Institutions Holding ESPR

# of Institutions
206
Shares Held
129M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $147M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email